{"id":"https://openalex.org/W2103040459","doi":"https://doi.org/10.2337/diabetes.48.4.758","title":"NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity.","display_name":"NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity.","alternate_titles":[],"publication_year":1999,"publication_date":"1999-04-01","ids":{"openalex":"https://openalex.org/W2103040459","doi":"https://doi.org/10.2337/diabetes.48.4.758","mag":"2103040459","pmid":"https://pubmed.ncbi.nlm.nih.gov/10102692"},"language":"en","primary_location":{"id":"doi:10.2337/diabetes.48.4.758","doi":"https://doi.org/10.2337/diabetes.48.4.758","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diabetes.48.4.758","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2103040459"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006863322","display_name":"Finbarr P.M. O'Harte","orcid":"https://orcid.org/0000-0002-7199-4239","observed_orcids":["https://orcid.org/0000-0002-7199-4239"]},"institutions":[{"id":"https://openalex.org/I138801177","display_name":"University of Ulster","ror":"https://ror.org/01yp9g959","country_code":"GB","type":"education","lineage":["https://openalex.org/I138801177"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F P O'Harte","raw_affiliation_strings":["School of Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland. fpm.oharte@ulst.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland. fpm.oharte@ulst.ac.uk","institution_ids":["https://openalex.org/I138801177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035566134","display_name":"Mark H. Mooney","orcid":"https://orcid.org/0000-0002-3600-341X","observed_orcids":["https://orcid.org/0000-0002-3600-341X"]},"institutions":[{"id":"https://openalex.org/I138801177","display_name":"University of Ulster","ror":"https://ror.org/01yp9g959","country_code":"GB","type":"education","lineage":["https://openalex.org/I138801177"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M H Mooney","raw_affiliation_strings":["School of Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland. fpm.oharte@ulst.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland. fpm.oharte@ulst.ac.uk","institution_ids":["https://openalex.org/I138801177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064124957","display_name":"Peter R. Flatt","orcid":"https://orcid.org/0000-0001-8548-7943","observed_orcids":["https://orcid.org/0000-0001-8548-7943"]},"institutions":[{"id":"https://openalex.org/I138801177","display_name":"University of Ulster","ror":"https://ror.org/01yp9g959","country_code":"GB","type":"education","lineage":["https://openalex.org/I138801177"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P R Flatt","raw_affiliation_strings":["School of Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland. fpm.oharte@ulst.ac.uk"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Biomedical Sciences, University of Ulster, Coleraine, Northern Ireland. fpm.oharte@ulst.ac.uk","institution_ids":["https://openalex.org/I138801177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I138801177"],"apc_list":null,"apc_paid":null,"fwci":3.8644,"has_fulltext":false,"cited_by_count":71,"citation_normalized_percentile":{"value":0.93802248,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"48","issue":"4","first_page":"758","last_page":"765"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucose-dependent-insulinotropic-polypeptide","display_name":"glucose-dependent insulinotropic polypeptide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dipeptidyl-peptidase-4","display_name":"dipeptidyl peptidase IV","score":0.9359999895095825},{"id":"https://openalex.org/keywords/antidiabetic-activity","display_name":"antidiabetic activity","score":0.9380000233650208},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.9179999828338623},{"id":"https://openalex.org/keywords/incretin-hormones","display_name":"incretins","score":0.7559999823570251},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.972000002861023},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.7319999933242798},{"id":"https://openalex.org/keywords/enteroinsular-axis","display_name":"enteroinsular axis","score":0.6859999895095825},{"id":"https://openalex.org/keywords/diprotin-a","display_name":"diprotin A","score":0.6869999766349792}],"concepts":[{"id":"https://openalex.org/C2776129832","wikidata":"https://www.wikidata.org/wiki/Q22677256","display_name":"Gastric inhibitory polypeptide","level":4,"score":0.9272446632385254},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8270450234413147},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.8042394518852234},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.7461129426956177},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.6470221281051636},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.5792841911315918},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5200559496879578},{"id":"https://openalex.org/C2781469919","wikidata":"https://www.wikidata.org/wiki/Q5279728","display_name":"Dipeptidyl peptidase","level":3,"score":0.4960881173610687},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.48696860671043396},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.4121726453304291},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.2761457860469818},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2638751268386841},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2634313404560089},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2419867217540741},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.231285959482193},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1927308440208435}],"mesh":[{"descriptor_ui":"D000626","descriptor_name":"Aminopeptidases","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005749","descriptor_name":"Gastric Inhibitory Polypeptide","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006706","descriptor_name":"Homeostasis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010949","descriptor_name":"Plasma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018629","descriptor_name":"Spectrometry, Mass, Secondary Ion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.2337/diabetes.48.4.758","doi":"https://doi.org/10.2337/diabetes.48.4.758","is_oa":false,"landing_page_url":"https://doi.org/10.2337/diabetes.48.4.758","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},{"id":"pmid:10102692","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10102692","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"Journal Article"},{"id":"pmh:oai:pure.qub.ac.uk/portal:publications/b232c1a3-e534-47b0-8497-55e49518cd0a","doi":null,"is_oa":false,"landing_page_url":"https://pure.qub.ac.uk/en/publications/b232c1a3-e534-47b0-8497-55e49518cd0a","pdf_url":null,"source":{"id":"https://openalex.org/S4306402319","display_name":"Research Portal (Queen's University Belfast)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I126231945","host_organization_name":"Queen's University Belfast","host_organization_lineage":["https://openalex.org/I126231945"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"O'Harte, F, Mooney, M & Flatt, P 1999, 'NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity', Diabetes, vol. 48 (4), no. 4, pp. 758-765.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1971103360","https://openalex.org/W1972481662","https://openalex.org/W1978953702","https://openalex.org/W1984170856","https://openalex.org/W2004890167","https://openalex.org/W2025375701","https://openalex.org/W2025551701","https://openalex.org/W2039166390","https://openalex.org/W2054764073","https://openalex.org/W2056594490","https://openalex.org/W2057802735","https://openalex.org/W2064492226","https://openalex.org/W2070027753","https://openalex.org/W2104763836","https://openalex.org/W2148182710","https://openalex.org/W2152960998","https://openalex.org/W2170599934","https://openalex.org/W4234825176"],"related_works":["https://openalex.org/W2097018460","https://openalex.org/W2109242743","https://openalex.org/W2028479574","https://openalex.org/W2009428928","https://openalex.org/W2114369058","https://openalex.org/W2118100404","https://openalex.org/W1985921802","https://openalex.org/W2108420279","https://openalex.org/W1978953702","https://openalex.org/W2127464316"],"abstract_inverted_index":{"Gastric":[0],"inhibitory":[1],"polypeptide":[2],"(GIP)":[3],"is":[4],"an":[5],"important":[6],"insulin-releasing":[7,66,276],"hormone":[8],"of":[9,24,53,56,71,95,103,120,128,136,149,201],"the":[10,41,51,188,191],"enteroinsular":[11],"axis":[12],"that,":[13],"like":[14],"glucagon-like":[15],"peptide":[16,151],"1(7-36)":[17],"amide":[18],"(tGLP-1),":[19],"has":[20],"a":[21,228],"functional":[22],"profile":[23],"possible":[25],"therapeutic":[26],"value":[27],"for":[28,194],"type":[29],"2":[30],"diabetes.":[31],"Both":[32],"incretin":[33],"hormones":[34],"are":[35],"rapidly":[36],"inactivated":[37],"in":[38,143,278],"plasma":[39,62,129,266],"by":[40,73,126],"exopeptidase":[42],"dipeptidyl":[43],"peptidase":[44],"(DPP)":[45],"IV.":[46],"The":[47,118],"present":[48],"study":[49],"examined":[50,142],"ability":[52],"NH2-terminal":[54],"modification":[55],"human":[57],"GIP":[58,72,96,107,111,137,140,203,206,238,240,262],"to":[59,99,115,265],"protect":[60],"from":[61],"degradation":[63,269],"and":[64,67,138,165,183,231,270,275],"enhance":[65],"antihyperglycemic":[68,273],"activity.":[69],"Degradation":[70],"incubation":[74],"at":[75,181],"37":[76],"degrees":[77],"C":[78],"with":[79,132,155,173,187,205,227],"purified":[80],"DPP":[81,130,267],"IV":[82,131,268],"was":[83,97,112,122,225],"clearly":[84],"evident":[85],"after":[86,146,169,199,236],"4":[87],"h":[88],"(54%":[89],"intact).":[90],"After":[91],"12":[92],"h,":[93],">60%":[94],"converted":[98],"GIP(3-42),":[100],"whereas":[101],">99%":[102],"NH2-terminally":[104],"modified":[105],"Tyr1-glucitol":[106,110,139,202,237,261],"remained":[108],"intact.":[109],"similarly":[113],"resistant":[114],"serum":[116],"degradation.":[117],"formation":[119],"GIP(3-42)":[121],"almost":[123],"completely":[124],"abolished":[125],"inhibition":[127],"diprotin":[133],"A.":[134],"Effects":[135],"were":[141,162,196],"Wistar":[144],"rats":[145],"intraperitoneal":[147],"injection":[148],"either":[150],"(10":[152],"nmol/kg)":[153],"together":[154,186],"glucose":[156,160,174,179,195],"(18":[157],"mmol/kg).":[158],"Plasma":[159],"concentrations":[161,167],"significantly":[163,197,229],"lower":[164,198],"insulin":[166,234],"higher":[168],"both":[170],"peptides":[171],"compared":[172,204],"alone.":[175],"More":[176],"importantly,":[177],"individual":[178],"values":[180],"15":[182],"30":[184],"min":[185],"areas":[189],"under":[190],"curve":[192],"(AUCs)":[193],"administration":[200],"(AUC":[207,241],"255":[208],"+/-":[209,213,243,247],"33":[210],"vs.":[211,245],"368":[212],"8":[214],"mmol":[215],"x":[216,218,250,252],"l(-1)":[217],"min(-1),":[219],"respectively;":[220],"P":[221,254],"<":[222,255],"0.01).":[223],"This":[224],"associated":[226],"greater":[230],"more":[232],"protracted":[233],"response":[235],"than":[239],"773":[242],"41":[244],"639":[246],"39":[248],"ng":[249],"ml(-1)":[251],"min(-1);":[253],"0.05).":[256],"These":[257],"data":[258],"demonstrate":[259],"that":[260],"displays":[263],"resistance":[264],"exhibits":[271],"enhanced":[272],"activity":[274],"action":[277],"vivo.":[279]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2103040459","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
